Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 11, Number 2, February 2019, pages 133-136

The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years

Tables

Table 1. Reference Oxology Evaluations of Study Groups
 
Group 1Group 2P
SDS: standard deviation score; PAH: predicted adult height.
Age8.0 ± 1.68.4 ± 1.40.62
Height138.7 ± 7.5136.4 ± 9.60.52
Height SDS1.3 ± 1.30.9 ± 1.30.54
PAH165.4 ± 7.9163.5 ± 8.10.51
PAH SDS0.5 ± 1.30.4 ± 1.30.84
Bone age9.7 ± 2.310.3 ± 2.10.69

 

Table 2. Height SDS and Delta Bone Age Values of the First and Second Years of the Study Groups
 
Group 1Group 2P
SDS: standard deviation score.
First year height SDS1.2 ± 1.41.3 ± 1.80.52
First year delta bone age SDS0.7 ± 0.50.5 ± 0.80.96
Second year height SDS1.1 ± 1.22.2 ± 0.50.10
Second year delta bone age SDS0.77 ± 0.51.0 ± 00.20

 

Table 3. The Target Height and Final Height of the Study Groups
 
Group 1Group 2P
Target height158.4 ± 5.1159.8 ± 5.80.40
Final height157.4 ± 8.4161.2 ± 7.40.16